These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9103397)
1. Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer. Vassilopoulou-Sellin R; Theriault R; Klein MJ Gynecol Oncol; 1997 Apr; 65(1):89-93. PubMed ID: 9103397 [TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer. Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929 [TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study. Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273 [TBL] [Abstract][Full Text] [Related]
4. Estrogen replacement therapy in breast cancer survivors: a matched-controlled series. Decker DA; Pettinga JE; VanderVelde N; Huang RR; Kestin L; Burdakin JH Menopause; 2003; 10(4):277-85. PubMed ID: 12851510 [TBL] [Abstract][Full Text] [Related]
5. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment. Ursic-Vrscaj M; Bebar S Eur J Surg Oncol; 1999 Apr; 25(2):146-51. PubMed ID: 10218456 [TBL] [Abstract][Full Text] [Related]
6. Estrogen replacement therapy after treatment for localized breast carcinoma. Patient responses and opinions. Vassilopoulou-Sellin R; Klein MJ Cancer; 1996 Sep; 78(5):1043-8. PubMed ID: 8780542 [TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS; J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331 [TBL] [Abstract][Full Text] [Related]
8. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer. Vassilopoulou-Sellin R; Theriault RL J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459 [TBL] [Abstract][Full Text] [Related]
9. An experience with estrogen replacement therapy in breast cancer survivors. Brewster WR; DiSaia PJ; Grosen EA; McGonigle KF; Kuykendall JL; Creasman WT Int J Fertil Womens Med; 1999; 44(4):186-92. PubMed ID: 10499739 [TBL] [Abstract][Full Text] [Related]
11. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
12. Recurrence in breast cancer. Analysis with frailty model. Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450 [TBL] [Abstract][Full Text] [Related]
13. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J; J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505 [TBL] [Abstract][Full Text] [Related]
14. Body weight correlates with mortality in early-stage breast cancer. Enger SM; Greif JM; Polikoff J; Press M Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612 [TBL] [Abstract][Full Text] [Related]
15. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455 [TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
17. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414 [TBL] [Abstract][Full Text] [Related]
18. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617 [TBL] [Abstract][Full Text] [Related]
19. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy. Fodor J; Major T; Polgár C; Tóth J; Németh G Neoplasma; 2000; 47(3):181-6. PubMed ID: 11043843 [TBL] [Abstract][Full Text] [Related]
20. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]